Topical antifungal vs placebo/no treatment
Health‐related quality of life (HRQL) · chronic rhinosinusitis
Topical antifungal may leads to lower heath‐related quality of life (HRQL) compared with placebo/no treatment (low certainty).
1 finding from 1 review
- Topical and systemic antifungal therapy for chronic rhinosinusitis 2018 · Cochrane Headline outcomes onlyno estimate extractedStudies not reportedLow